Now At-Home & Virtually Guided

Meet our clinical team

THEIR EXPERTISE

Our board of experts are trailblazers in the fields of psychedelic research, ketamine therapy, and clinical psychology. They guide the clinical protocols to ensure your experiences are safe and science-backed.

Medical Director

Leonardo Vando, MD

Dr. Leonardo Vando is a Board Certified Psychiatrist and Addiction Psychiatrist with over 15 years of experience in treating the full spectrum of psychiatric and addictive disorders...

Meet Dr. Paleos
Read more

Leonardo Vando, MD

Dr. Leonardo Vando is a Board Certified Psychiatrist and Addiction Psychiatrist with over 15 years of experience in treating the full spectrum of psychiatric and addictive disorders. He specializes in treating complex conditions requiring integration of genetic, metabolic, cultural and psychosocial data points in order to achieve reduction of symptoms and promote healing.

Dr. Vando has been at the forefront of ketamine use in clinical practice, developing intramuscular protocols to achieve rapid results and minimize adverse events for treatment-resistant depression and addictive disorders, with a focus on increasing access to treatment in low income communities. He is also contributing to the field of psychedelic medicine through his work and research on microdosing for mental illness.

He attended Sacred Heart University as a chemistry undergrad and received a medical degree from Ponce School of Medicine. He trained as a psychiatrist and addictionologist in NYC’s Beth Israel Medical Center. He currently resides in New York, where he has worked in private practice for over a decade.

Read more

Casey Paleos, MD

Dr. Casey Paleos is a board certified psychiatrist with over a decade of experience working with ketamine and other psychedelic medicines in both research and clinical settings. A Co-Principal Investigator for the NYU-Bellevue Ketamine for Depression Study, Dr. Paleos was one of the early researchers to identify ketamine as a breakthrough treatment for depression. As a clinician, he has been treating patients for depression and anxiety using ketamine therapy in his New York private practice since 2016.

In addition to his work with ketamine, Dr. Paleos has helped advance research in other areas of psychedelic medicine. Today, he serves as a Co-Principal Investigator for the MAPS-sponsored MDMA-Assisted Psychotherapy for PTSD Phase 3 Clinical Trials. Previously, he was a Co-Principal Investigator for the MDMA-Assisted Psychotherapy Phase 2 Clinical Trials and a Study Therapist for the NYU Psilocybin Cancer Anxiety Study.

Dr. Paleos received his M.D. from University of Pittsburgh School of Medicine and completed his residency training at NYU/Bellevue Medical Center. He earned his Bachelor of Science from Cornell University.


Medical Advisor

Teddy Akiki, MD

Dr. Teddy Akiki is a foremost research specialist in the neuroscience of ketamine, the neural basis of stress-related and trauma-related psychiatric disorders, and glutamatergic Rapid-Acting Antidepressants (RAADs)...

Meet Dr. Paleos
Read more

Teddy Akiki, MD

Dr. Teddy Akiki is a foremost research specialist in the neuroscience of ketamine, the neural basis of stress-related and trauma-related psychiatric disorders, and glutamatergic Rapid-Acting Antidepressants (RAADs). His research combines functional and structural neuroimaging, psychopharmacological trials, and computational and network neuroscience methodology.

Currently conducting research at the Cleveland Clinic’s esteemed Neurological Institute, Dr. Akiki started his neuroscience research as a Postdoctoral Fellow at the Yale University Department of Psychiatry, where the antidepressant effects of ketamine were first described over two decades ago.

Dr. Akiki received his M.D. from the American University of Beirut where his doctoral research consisted of developing novel biomarkers in the context of neuromodulation and treatment-resistant depression. Dr. Akiki served as editor for Elsevier’s Psychology and Psychiatry journal and has published over fifteen peer-reviewed articles in science journals including ScienceDirect and SAGE Chronic Stress journal.

Medical Advisor

Cameron Sepah, PhD

Dr. Cameron Sepah is an Assistant Clinical Professor in UCSF Medical School's Department of Psychiatry, where he has been awarded the Excellence in Teaching award for training Psychiatry residents in evidence-based therapies including CBT and ACT...

Meet Dr. Paleos
Read more

Cameron Sepah, PhD

Dr. Cameron Sepah is an Assistant Clinical Professor in UCSF Medical School's Department of Psychiatry, where he has been awarded the Excellence in Teaching award for training Psychiatry residents in evidence-based therapies including CBT and ACT. Previously, Dr. Sepah was Founding Team Member & VP of Clinical Innovation at Omada Health, the leading digital therapeutics company for chronic diseases. He has been awarded research grants from the National Institute of Health and National Science Foundation, and today invests in and advises health care technology companies.

Dr. Sepah received his PhD in Clinical Psychology, focusing on PsychoNeuroImmunology, from UCLA and completed his residency & fellowship at UCSD/San Diego/Chicago VA in Behavioral Medicine, after graduating from Harvard University with an undergraduate degree in Psychology, focusing on Cognitive Neuroscience.

Psychiatric Nurse Practitioner Advocate

Kristin Arden, PMHNP-BC

Kristin represents the voice of the Psychiatric Nurse Practitioner at Mindbloom. She is a board-certified Psychiatric NP with over 15 years of experience working in mental health.

Meet Dr. Paleos
Read more

Kristin Arden, PMHNP-BC

Kristin represents the voice of the Psychiatric Nurse Practitioner at Mindbloom. She is a board-certified Psychiatric NP with over 15 years of experience working in mental health. She spent nearly a decade in the California state hospital system working with some of our nation’s most vulnerable. Driven by her passion to increase access to mental care, she’s been at the forefront of integrating technology into care delivery models with early roles at cutting edge health-tech start-ups including Oscar and Call9, and by bringing telemental health to the Brooklyn VA Hospital.

As a clinician, Kristin is a proponent for alternative forms of treatment such as psychedelic medicines and treated the first cohort of clients at Mindbloom. Her approach to treatment is one that is client-centered driven by the ethos of harm reduction. In addition to her clinical practice, she is a guest lecturer at NYU-School of Nursing on topics such as psychedelic therapy and substance use disorders.

Kristin graduated from NYU’s Psychiatric Nurse Practitioner program and specialty track in substance use and addictions where she received the distinguished student award. She is currently pursuing her DNP at Rush University.

Our Doctors
Am I a candidate?